Search - tctmd.com

Displaying 301 - 320 of 870

Sort: Relevancy | Date

Presentation THT 2022

PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts!

Presenter: Roham Zamanian

February 01, 2022

Presentation THT 2022

CON - PRO - LA decompression is unnecessary in the era of SGLT2 inhibitors and ARNI's!

Presenter: Sanjiv Shah

February 01, 2022

Presentation THT 2022

PRO - LA decompression is unnecessary in the era of SGLT2 inhibitors and ARNI's!

Presenter: Alanna Morris

February 01, 2022

Presentation THT 2022

Right heart catheterization + Exercise testing – best practices for treatment selection in patients with PH due to Left Heart Disease

Presenter: Ryan Tedford

February 01, 2022

Presentation THT 2022

Timing of Intervention and the fate of the RV

Presenter: Barry Borlaug

February 01, 2022

Presentation THT 2022

Why should we do this?

Presenter: William Abraham

February 01, 2022

Presentation TCT 2021

FUROSCIX CRLs (scPharmaceuticals)

Presenter: Daniel Bensimhon

November 06, 2021

Presentation TCT 2021

AquaPass

Presenter: Doron Aronson

November 06, 2021

Presentation TCT 2021

Treating the Lymphatic System for Acute and Chronic HF

Presenter: Marat Fudim

November 06, 2021

Presentation TCT 2021

New Approaches to Diuresis - Reprieve

Presenter: Jeffrey Testani

November 06, 2021

Presentation TCT 2021

Manipulation of Renal Preload and Afterload for Acute Decompensated Heart Failure

Presenter: Navin Kapur

November 06, 2021

Presentation TCT 2021

ADHF Pathophysiology and Emerging Devices (DRIIPPS)

Presenter: W. H. Wilson Tang

November 06, 2021

Presentation TCT 2021

Indirect Annuloplasty Technology- Lessons Learned Over the Past Decade

Presenter: Samir Kapadia

November 06, 2021

Presentation TCT 2021

TCT 539: Use of Percutaneous Intra-aortic Mechanical Circulatory Support to Treat Acute Decompensated Heart Failure With Worsening Renal Function

Presenter: Mir Basir

November 04, 2021

Presentation TCT 2021

TCT 538: Percutaneous Decommissioning of a HeartWare Left Ventricular Assist Device in a Patient With Myocardial Recovery

Presenter: Carey Kimmelstiel

November 04, 2021

Presentation TCT 2021

TCT 615: Decommissioning Of Left Ventricular Assist Device by Percutaneous Closure of Outflow Graft Using VSD occluder device and Amplatzer Vascular Plug

Presenter: Mohit Pahuja

November 04, 2021

Presentation TCT 2021

Debate 2: Con – The ISCHEMIA Results Apply to All Revascularization; We All Need to Reconsider Our Approach

Presenter: Sripal Bangalore

November 04, 2021

Presentation TCT 2021

Debate 2: Pro – The ISCHEMIA Trial Results Do Not Apply to CABG; Our Outcomes Are Different!

Presenter: Mario Gaudino

November 04, 2021

Presentation TCT 2021

Debate 1: Con – Anatomy First; NICE Guidelines Got It Right

Presenter: Nick Curzen

November 04, 2021

Presentation TCT 2021

Debate 1: Pro – Functional Testing Matters; We Need to Follow the ACC/AHA Guidelines

Presenter: Raymond Kwong

November 04, 2021

Advertisement

PRO - Patients with Group 2 Pulmonary Hypertension are not candidates for interatrial shunts!

CON - PRO - LA decompression is unnecessary in the era of SGLT2 inhibitors and ARNI's!

PRO - LA decompression is unnecessary in the era of SGLT2 inhibitors and ARNI's!

Right heart catheterization + Exercise testing – best practices for treatment selection in patients with PH due to Left Heart Disease

Timing of Intervention and the fate of the RV

Why should we do this?

FUROSCIX CRLs (scPharmaceuticals)

AquaPass

Treating the Lymphatic System for Acute and Chronic HF

New Approaches to Diuresis - Reprieve

Manipulation of Renal Preload and Afterload for Acute Decompensated Heart Failure

ADHF Pathophysiology and Emerging Devices (DRIIPPS)

Indirect Annuloplasty Technology- Lessons Learned Over the Past Decade

TCT 539: Use of Percutaneous Intra-aortic Mechanical Circulatory Support to Treat Acute Decompensated Heart Failure With Worsening Renal Function

TCT 538: Percutaneous Decommissioning of a HeartWare Left Ventricular Assist Device in a Patient With Myocardial Recovery

TCT 615: Decommissioning Of Left Ventricular Assist Device by Percutaneous Closure of Outflow Graft Using VSD occluder device and Amplatzer Vascular Plug

Debate 2: Con – The ISCHEMIA Results Apply to All Revascularization; We All Need to Reconsider Our Approach

Debate 2: Pro – The ISCHEMIA Trial Results Do Not Apply to CABG; Our Outcomes Are Different!

Debate 1: Con – Anatomy First; NICE Guidelines Got It Right

Debate 1: Pro – Functional Testing Matters; We Need to Follow the ACC/AHA Guidelines

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content